Urea-induced Denaturation of Apolipoprotein Serum Amyloid A Reveals Marginal Stability of Hexamer

Overview

Journal Protein Sci

Specialty Biochemistry

Date 2005 Jun 7

PMID 15937280

Citations 7

Authors

Limin Wang

Wilfredo Colon

Affiliations

Soon will be listed here.

Abstract

Serum Amyloid A (SAA) is an acute phase reactant protein that is predominantly found bound to high-density lipoprotein in plasma. Upon inflammation, the plasma concentration of SAA can increase dramatically, occasionally leading to the development of amyloid A (AA) amyloidosis, which involves the deposition of SAA amyloid fibrils in major organs. We previously found that the murine isoform SAA2.2 exists in aqueous solution as a hexamer containing a central channel. Here we show using various biophysical and biochemical techniques that the SAA2.2 hexamer can be totally dissociated into monomer by approximately 2 M urea, with the concerted loss of its alpha-helical structure. However, limited trypsin proteolysis experiments in urea showed a conserved digestion profile, suggesting the preservation of major backbone topological features in the urea-denatured state of SAA2.2. The marginal stability of hexameric SAA2.2 and the presence of residual structure in the denatured monomeric protein suggest that both forms may interconvert in vivo to exert different functions to meet the various needs during normal physiological conditions and in response to inflammatory stimuli.

Citing Articles

Diabetes mellitus drug discovery: insights into targeting feline and human amylin with small molecules.

Moore K, Horgan N, Lenters B, Fortin J Vet Q. 2023; 43(1):1-12.

PMID: 37729105 PMC: 10557562. DOI: 10.1080/01652176.2023.2260442.

Interleukin-1β Induces Intracellular Serum Amyloid A1 Expression in Human Coronary Artery Endothelial Cells and Promotes its Intercellular Exchange.

Kuret T, Sodin-Semrl S, Mrak-Poljsak K, cucnik S, Lakota K, Erman A Inflammation. 2019; 42(4):1413-1425.

PMID: 31011929 DOI: 10.1007/s10753-019-01003-3.

Divergent effect of glycosaminoglycans on the in vitro aggregation of serum amyloid A.

Aguilera J, Zhang F, Beaudet J, Linhardt R, Colon W Biochimie. 2014; 104:70-80.

PMID: 24878279 PMC: 4119840. DOI: 10.1016/j.biochi.2014.05.007.

Characterization of the oligomerization and aggregation of human Serum Amyloid A.

Patke S, Srinivasan S, Maheshwari R, Srivastava S, Aguilera J, Colon W PLoS One. 2013; 8(6):e64974.

PMID: 23750222 PMC: 3672174. DOI: 10.1371/journal.pone.0064974.

Pathogenic serum amyloid A 1.1 shows a long oligomer-rich fibrillation lag phase contrary to the highly amyloidogenic non-pathogenic SAA2.2.

Srinivasan S, Patke S, Wang Y, Ye Z, Litt J, Srivastava S J Biol Chem. 2012; 288(4):2744-55.

PMID: 23223242 PMC: 3554940. DOI: 10.1074/jbc.M112.394155.

References

Wright P, Dyson H . Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. J Mol Biol. 1999; 293(2):321-31. DOI: 10.1006/jmbi.1999.3110. View

Wang L, Lashuel H, Colon W . From hexamer to amyloid: marginal stability of apolipoprotein SAA2.2 leads to in vitro fibril formation at physiological temperature. Amyloid. 2005; 12(3):139-48. DOI: 10.1080/13506120500223084. View

Gillmore J, Lovat L, Persey M, Pepys M, Hawkins P . Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet. 2001; 358(9275):24-9. DOI: 10.1016/S0140-6736(00)05252-1. View

Saadeddin S, Habbab M, Ferns G . Markers of inflammation and coronary artery disease. Med Sci Monit. 2002; 8(1):RA5-12. View

Delanghe J, Langlois M, De Bacquer D, Mak R, Capel P, Van Renterghem L . Discriminative value of serum amyloid A and other acute-phase proteins for coronary heart disease. Atherosclerosis. 2002; 160(2):471-6. DOI: 10.1016/s0021-9150(01)00607-4. View

Libby P, Ridker P, Maseri A . Inflammation and atherosclerosis. Circulation. 2002; 105(9):1135-43. DOI: 10.1161/hc0902.104353. View

Uversky V . Natively unfolded proteins: a point where biology waits for physics. Protein Sci. 2002; 11(4):739-56. PMC: 2373528. DOI: 10.1110/ps.4210102. View

Wang L, Lashuel H, Walz T, Colon W . Murine apolipoprotein serum amyloid A in solution forms a hexamer containing a central channel. Proc Natl Acad Sci U S A. 2002; 99(25):15947-52. PMC: 138545. DOI: 10.1073/pnas.252508399. View

Wang L, Colon W . The interaction between apolipoprotein serum amyloid A and high-density lipoprotein. Biochem Biophys Res Commun. 2004; 317(1):157-61. DOI: 10.1016/j.bbrc.2004.03.027. View

10.

McAdam K, Sipe J . Murine model for human secondary amyloidosis: genetic variability of the acute-phase serum protein SAA response to endotoxins and casein. J Exp Med. 1976; 144(4):1121-7. PMC: 2190436. DOI: 10.1084/jem.144.4.1121. View

11.

BENDITT E, Eriksen N . Amyloid protein SAA is associated with high density lipoprotein from human serum. Proc Natl Acad Sci U S A. 1977; 74(9):4025-8. PMC: 431828. DOI: 10.1073/pnas.74.9.4025. View

12.

Husebekk A, Skogen B, Husby G, Marhaug G . Transformation of amyloid precursor SAA to protein AA and incorporation in amyloid fibrils in vivo. Scand J Immunol. 1985; 21(3):283-7. DOI: 10.1111/j.1365-3083.1985.tb01431.x. View

13.

Turnell W, Sarra R, Glover I, Baum J, Caspi D, Baltz M . Secondary structure prediction of human SAA1. Presumptive identification of calcium and lipid binding sites. Mol Biol Med. 1986; 3(5):387-407. View

14.

Craig W . Determination of quaternary structure of an active enzyme using chemical cross-linking with glutaraldehyde. Methods Enzymol. 1988; 156:333-45. DOI: 10.1016/0076-6879(88)56034-2. View

15.

Eftink M . The use of fluorescence methods to monitor unfolding transitions in proteins. Biophys J. 1994; 66(2 Pt 1):482-501. PMC: 1275715. DOI: 10.1016/s0006-3495(94)80799-4. View

16.

Uhlar C, Burgess C, Sharp P, WHITEHEAD A . Evolution of the serum amyloid A (SAA) protein superfamily. Genomics. 1994; 19(2):228-35. DOI: 10.1006/geno.1994.1052. View

17.

Levartowsky D, Prass M, Hershkoviz R, Lider O, Fridkin M . Inhibition of cell adhesion to glycoproteins of the extracellular matrix by peptides corresponding to serum amyloid A. Toward understanding the physiological role of an enigmatic protein. Eur J Biochem. 1994; 223(1):35-42. DOI: 10.1111/j.1432-1033.1994.tb18963.x. View

18.

Yamada T, Kluve-Beckerman B, Liepnieks J, Benson M . Fibril formation from recombinant human serum amyloid A. Biochim Biophys Acta. 1994; 1226(3):323-9. DOI: 10.1016/0925-4439(94)90044-2. View

19.

Checovich W, Bolger R, Burke T . Fluorescence polarization--a new tool for cell and molecular biology. Nature. 1995; 375(6528):254-6. DOI: 10.1038/375254a0. View

20.

Patel H, Bramall J, Waters H, de Beer M, Woo P . Expression of recombinant human serum amyloid A in mammalian cells and demonstration of the region necessary for high-density lipoprotein binding and amyloid fibril formation by site-directed mutagenesis. Biochem J. 1996; 318 ( Pt 3):1041-9. PMC: 1217721. DOI: 10.1042/bj3181041. View